JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2023  1,500
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 58(2024) N 6 p. 1074-1081; DOI 10.1134/S0026893324700572 Full Text

V.M. Puchkov1, A.D. Lyfenko1, V.S. Koval1, S.V. Revtovich1, V.V. Kulikova1, N.V. Anufrieva1, A.S. Zemskaya1, E.A. Morozova1*, P.N. Solyev1

Synthesis and Antimicrobial Activity of Thiosulfinates and Allicin Analogues

1Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991 Russia

*elmorozova@yahoo.com
Received - 2024-04-17; Revised - 2024-06-13; Accepted - 2024-06-18

Diallyl thiosulfinate (allicin) effectively inhibits the growth of various microorganisms, including antibiotic-resistant strains, so it can be considered to be a broad-spectrum antimicrobial compound. However, its instability in the bloodstream hinders its use as a therapeutic agent. We have synthesized a number of allicin analogues, both natural and synthetic, and evaluated in vitro their antimicrobial properties against Staphylococcus aureus and Candida albicans. The synthesized compounds were shown to exhibited more pronounced antifungal activity than antibacterial. Among the compounds obtained, synthetic di-(2,2,2-trichloroethyl) ester of 3,3'-[(thio)sulfinyl]dipropionic acid effectively inhibited the growth of both fungi and bacteria at concentrations comparable to those of known antimicrobial agents used in medical practice.

allicin, thiosulfinates, antimicrobial activity, polymicrobial infection, Staphylococcus aureus, Candida albicans



JMB-FOOTER RAS-JOURNALS